[1] |
HOU Tiantian, WANG Xudong, YANG Ping, ZHOU Pengbo, QIN Chao, HUANG Ying, WANG Ailing, GENG Xingchao, ZHOU Xiaobing, LIU Defang.
Biodistribution of Therapeutic DNA Vaccines in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 58-66.
|
[2] |
WANG Yijin, TANG Jing, YANG Chao, XU Kai, ZHANG Mengdie, GAO Jian, WU Xiaoli, ZHANG Yue, NIU Xiaobing, JIANG Hesong, MAO Fei, ZHOU Shan, JIANG Xi, GUO Zhongying, SUN Su'an, XU Ming, XU Zongyuan, WANG Hengbing, LI Xin, FU Guangbo.
Clinical research of submucosal low-dose gemcitabine injection combined with transurethral resection of bladder tumor in the treatment of medium-high risk non-muscle invasive bladder cancer
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1044-1050.
|
[3] |
LIU Wendong, CUI Huanhuan, WANG Xiaohan, SU Xian, WANG Haixue.
Status and thinking of Parmacovigilance regulatory system during clinical trials of the pediatric drug in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1002-1006.
|
[4] |
HUANG Ying, WEN Hairuo, HOU Tiantian, HUO Yan, WANG Sanlong, GENG Xingchao.
Cloning ability of CAR-T cells in soft agar and tumorigenicity in vitro
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 836-838.
|
[5] |
HUANG Ying, HOU Tiantian, QIN Chao, HUO Yan, WANG Sanlong, WEN Hairuo, GENG Xingchao.
Nonclinical research on CAR-T cell products: main concerns and key issues
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 813-816.
|
[6] |
YANG Ming, LUO Hui, LIU Jianping.
Progress in Methods of Research into Clinical Interactions between Traditional Chinese Medicine and Chemical Medicine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1029-1033.
|
[7] |
CHENG Jinlian, OUYANG Huitian, JIN Hongtao, ZHU Xueqi, XIAO Shuang, LEI Xiang, GAO Chunsheng, LIU Qingquan.
Thoughts and Suggestions on Safety Evaluation of Combined use of Traditional Chinese Medicine in Clinical Research
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 4-10.
|
[8] |
LI Qing-na ,LU Fang GAO Rui.
Discussion on the Reporting Standards and Quality of Adverse Events in Clinical Researches
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(5): 302-304.
|
[9] |
WANG Yan-chun, LI Xu-dong, LIU Ying, FENG Ying.
Study on Solvent Compatibility of Shuxuening Injection
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(5): 309-311.
|
[10] |
WANG Su-mei, WU Cheng-sheng, LUAN Yong-fu, SUN Rong.
Study and Thought about Establishment Method of Clinical Effect Evaluation System Mode of Diabetes Complications
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(3): 137-139.
|
[11] |
WANG Chun-ting, LI Yu-ji, XIA Dong-sheng ,TIAN Chun-hua.
The Situation and Countermeasure of Current Children's Medicine
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(8): 492-496.
|